The Ontario Genomics Institute (OGI) Science with Industry workshop program and MaRS Future of Medicine series joined forces to present a one-day workshop on molecular diagnostics.  Dx2010 Markers to Market brought together leading international researchers, regulatory representatives and entrepreneurs from the diagnostics sector to examine regulatory hurdles and commercialization challenges on the path from biomarker discovery to market for molecular diagnostics and prognostics.

Speakers at the event included:

• Greg Hines, CEO, ArcticDX
• Elizabeth Mansfield, Director of Personalized Medicine, FDA
• Thomas Metcalfe, Head, Science and Technology Incubator, Translational Research Sciences (TRS), Roche
• Allen Roses, Director of Deane Drug Discovery Institute, Duke University
• Patrice Sarrazin, Senior Scientific Evaluator, Health Canada
• Lisette Stork-Sloots, Senior Program Director, Agendia

The 70 workshop participants represented academic, investment and commercial institutions active in the diagnostic discovery and product development sector of life sciences, and included researchers, entrepreneurs, intellectual property experts, and venture capital investors.

As part of the event, OGI Science with Industry and MaRS Future of Medicine interviewed the speakers and also several attendees on a range of topics related to diagnostics and the topics covered during the symposium. You can watch the interviews here.